Cervical cancer is the third most common cancer in women worldwide, with concepts and
knowledge about its prevention and treatment evolving rapidly. Human papillomavirus …

Besides classic tobacco and alcohol risk factors, human papillomavirus (HPV) plays a role in
the development of a subset of head and neck squamous cell carcinomas (HNSCCs), and …

Background Cervical cancer (CC) remains a leading cause of gynaecological cancer-
related mortality with infection by human papilloma virus (HPV) being the most important risk …

Specific human papillomavirus genotypes are associated with most ano‐genital carcinomas
and a large subset of oro‐pharyngeal carcinomas. Human papillomavirus DNA is thus a …

Purpose: Almost all cervical cancers are caused by human papillomavirus (HPV) and
patients with advanced stage are at high risk for relapse. Circulating HPV DNA (HPV ctDNA) …

Human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma (OPSCC) is
associated with improved outcomes compared to non-virally mediated disease. Clinical …

Cervical cancer is the first identified human papillomavirus (HPV) associated cancer and the
most promising malignancy to be eliminated. However, the ever-changing virus subtypes …

Recurrent oncogenic drivers have been identified in a variety of sweat gland tumors.
Recently, integration of human papillomavirus type 42 (HPV42) has been reported in digital …

Purpose: Use of circulating tumor DNA (ctDNA) for diagnosis is limited regarding the low
number of target molecules in early-stage tumors. Human papillomavirus (HPV)–associated …

Human papillomavirus (HPV) infection is responsible for approximately 5% of all cancers
and is associated with 30% of all pathogen-related cancers. Cervical cancer is the third most …